Your browser doesn't support javascript.
loading
Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade.
Luo, Hao; Liu, Gao-Lei; Jian, Dan; Liang, Dan-Dan; Li, Xue-Mei; Zhong, Li; Yang, Bo; Jiang, Jun; Wang, Dong; Li, Meng-Xia; Lan, Wei-Hua; Dai, Nan.
Afiliación
  • Luo H; Department of Oncology, Army Medical Center, Chongqing 400042, China.
  • Liu GL; Department of Urology, Army Medical Center, Chongqing 400042, China.
  • Jian D; Department of Oncology, Army Medical Center, Chongqing 400042, China.
  • Liang DD; Department of Oncology, Army Medical Center, Chongqing 400042, China.
  • Li XM; Department of Oncology, Army Medical Center, Chongqing 400042, China.
  • Zhong L; Department of Oncology, Army Medical Center, Chongqing 400042, China.
  • Yang B; Department of Oncology, Army Medical Center, Chongqing 400042, China.
  • Jiang J; Department of Urology, Army Medical Center, Chongqing 400042, China.
  • Wang D; Department of Oncology, Army Medical Center, Chongqing 400042, China.
  • Li MX; Department of Oncology, Army Medical Center, Chongqing 400042, China.
  • Lan WH; Department of Urology, Army Medical Center, Chongqing 400042, China.
  • Dai N; Department of Oncology, Army Medical Center, Chongqing 400042, China.
J Immunol Res ; 2022: 9962397, 2022.
Article en En | MEDLINE | ID: mdl-35915657
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Terapia Neoadyuvante Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Immunol Res Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Terapia Neoadyuvante Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Immunol Res Año: 2022 Tipo del documento: Article País de afiliación: China